Systemic Anti-Cancer Therapy Data Set

DEMOGRAPHICS AND CONSULTANT

To carry details for the demographics and consultant.
One occurrence of this group is required.
M/RData Set Data Elements
MNHS NUMBER
or
LOCAL PATIENT IDENTIFIER (EXTENDED)
MNHS NUMBER STATUS INDICATOR CODE
MPERSON FAMILY NAME
MPERSON GIVEN NAME
MPERSON BIRTH DATE
RPERSON STATED GENDER CODE
MPOSTCODE OF USUAL ADDRESS
RCONSULTANT CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY)
RCARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY)
MORGANISATION IDENTIFIER (CODE OF PROVIDER)

CLINICAL STATUS

To carry the clinical status details.
One occurrence of this group is required.
M/OData Set Data Elements
MPRIMARY DIAGNOSIS (ICD AT START SYSTEMIC ANTI-CANCER THERAPY)
and/or
MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY)
ODIAGNOSIS (SNOMED CT)

REGIMEN

To carry details of the Systemic Anti-Cancer Drug Regimen.
One occurrence of this group is permitted.
M/RData Set Data Elements
RADJUNCTIVE THERAPY TYPE
RSYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN TREATMENT INTENT
Up to four occurrences of this item are permitted
MSYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN ACRONYM
RPERSON HEIGHT IN METRES (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
RPERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
RPERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
RCO-MORBIDITY ADJUSTMENT INDICATOR
RDECISION TO TREAT DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
MSTART DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
RCLINICAL TRIAL INDICATOR

CYCLE

To carry details of each Systemic Anti-Cancer Therapy Cycle.
Multiple occurrences of this group are permitted. One for each Systemic Anti-Cancer Therapy Cycle.
M/RData Set Data Elements
RSYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE IDENTIFIER
MSTART DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)
RPERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)
RPERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)

DRUG DETAILS

To carry details of the Systemic Anti-Cancer Therapy Drugs for the patients treatment.
Multiple occurrences of this group are permitted. One for each Systemic Anti-Cancer Therapy Drug.
M/R/O/PData Set Data Elements
MSYSTEMIC ANTI-CANCER THERAPY DRUG NAME
PSYSTEMIC ANTI-CANCER THERAPY DRUG (SNOMED CT DM+D)
RSYSTEMIC ANTI-CANCER THERAPY ACTUAL DOSE
RUNIT OF MEASUREMENT (SYSTEMIC ANTI-CANCER THERAPY)
ROTHER UNIT OF MEASUREMENT DESCRIPTION (SYSTEMIC ANTI-CANCER THERAPY)
OUNIT OF MEASUREMENT (SNOMED CT DM+D)
RSYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
OROUTE OF ADMINISTRATION (SNOMED CT DM+D)
MSYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION DATE
RORGANISATION IDENTIFIER (OF SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION)

OUTCOME

To carry details of the outcome applicable to the patient's treatment.
One occurrence of this group is permitted.
R/PData Set Data Elements
RSYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN MODIFICATION INDICATOR (DOSE REDUCTION)
RSYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT COMPLETED AS PLANNED INDICATOR
RSYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT NOT COMPLETED OUTCOME REASON
Up to four occurrences of this item are permitted
ROTHER SYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT NOT COMPLETED OUTCOME REASON
RSYSTEMIC ANTI-CANCER THERAPY NON CURATIVE TREATMENT PATIENT BENEFIT INDICATOR
PSYSTEMIC ANTI-CANCER THERAPY TOXICITY MODIFICATION INDICATOR
ISO 9001 CERTIFICATION EUROPE